N/A
Completed N=3,776
Drug Utilization Study on the Prescribing Indications for Yasmin® and Other OCs in Croatia
Source: ClinicalTrials.gov NCT01319500 ↗Enrolled (actual)
3,776
Serious AEs
—
Results posted
Nov 2012
Primary outcomePrimary: OC Prescriptions by Treatment Group and Prescribing Medical Specialists — 244; 331; 929; 2213 Prescribing physicians
Summary
This study investigates the drug utilization pattern of Oral Contraceptives (OC) in Croatia. Gynecologists and Dermatologists were asked to contribute OC prescribing data to this study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY OC Prescriptions by Treatment Group and Prescribing Medical Specialists |
244; 331; 929; 2213; 14; 45 | — |
| PRIMARY Reasons for OC Prescriptions |
53.8; 57.8; 38.8; 29.7; 5.2; 11.6 | — |
| PRIMARY Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for "Contraceptive and Non-contraceptive" and "Non-contraceptive Only" Reasons |
226; 338; 212; 246; 199; 405 | — |
| PRIMARY Non-contraceptive Reasons for OC Prescriptions (Reported by Women Who Used OCs for Non-contraceptive Reasons Only) |
29; 131; 22; 97; 15; 40 | — |
| PRIMARY Reasons for OC Prescriptions by Gynecologists and Dermatologists |
2130; 347; 1783; 5; 2135; 1201 | — |
Eligibility Criteria
Inclusion Criteria
- women with an OC prescription during the timeframe (Feb-March 2011)
Data sourced from ClinicalTrials.gov (NCT01319500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.